IPSEN BIOPHARMACEUTICALS, INC.

Lobbying client · New Jersey · filed 2025 to 2026

Biopharmaceutical company.

$120,000 Reported spend

6 Filings counted

1 Firms hired

2 Bills named

Spend is reported income plus in-house expenses across 6 filings. Everything on this page is grouped by the client's LDA id (193515), not by name.

Firms hired 1

W STRATEGIES, LLC $120,000 6 filings

Bills named in these filings 2

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

1 filing
HR 5376
Impacts and Outcomes for Health Career Training Act

1 filing

Reported by year 2 years

2026 $40,000 2 filings
2025 $80,000 4 filings

Issues lobbied 1

Medicare/Medicaid 6

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Recent filings 6 total

Q2

W STRATEGIES, LLC

2nd Quarter (Apr 1 - June 30) 2026 · $20,000 income · posted Jul 20, 2026

View → Q1

W STRATEGIES, LLC

1st Quarter (Jan 1 - Mar 31) 2026 · $20,000 income · posted Apr 18, 2026

View → Q4

W STRATEGIES, LLC

4th Quarter (Oct 1 - Dec 31) 2025 · $20,000 income · posted Jan 20, 2026

View → Q3

W STRATEGIES, LLC

3rd Quarter (July 1 - Sep 30) 2025 · $20,000 income · posted Oct 20, 2025

View → Q2

W STRATEGIES, LLC

2nd Quarter (Apr 1 - June 30) 2025 · $20,000 income · posted Jul 18, 2025

View → Q1

W STRATEGIES, LLC

1st Quarter (Jan 1 - Mar 31) 2025 · $20,000 income · posted Apr 18, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.